Dr. Lodge is the Chief Science and Innovation Officer at Cellero. She has a strong background in cell-based therapeutics and immunology, including a Ph.D. in Cell and Molecular Biology from the University of Vermont and a postdoctoral fellowship with the Multiple Sclerosis Society studying the role of T cells in the disease process. Learn more about Dr. Lodge.

Ask A Scientist: What Antigens Can Stimulate IFNγ Producing CD8+ T Cells?

A curious researcher recently asked us to suggest suitable antigens that could stimulate IFNγ producing CD8+ T cells.  The short answer: Virus proteins.  But as with anything in immunology and virology, there is a longer, more complicated explanation as well.    Protein Antigens vs. Peptide Antigens CD8+ T cells normally recognize antigens that are produced…

Key Biologics Fills Critical Leadership Positions for High-Growth Business

Laurie Vertuccio named Director of Marketing and Rhonda Lyons named Director of Operations MEMPHIS, Tenn. and BOTHELL, Wash. — Jan. 30, 2020 — Key Biologics, the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today announced it has hired two new executives to support its recent growth…

Breaking from AACR: Profiling the TCR Beta Repertoire in NSCLC Donors

TCRβ sequencing is currently being explored in oncology research as a potential predictor for patient response to immunotherapies.   Researchers from Biodesix, Inc. shared their most recent findings in this area at the AACR Advances in Liquid Biopsies conference in Miami from January 13–16, 2020. The research, co-authored by our Benjamin Tjoa, evaluated peripheral blood lymphocytes…